TGTX logo

TG Therapeutics (TGTX) Operating profit

annual operating profit:

$41.93M+$21.30M(+103.21%)
December 31, 2024

Summary

  • As of today (June 22, 2025), TGTX annual operating income is $41.93 million, with the most recent change of +$21.30 million (+103.21%) on December 31, 2024.
  • During the last 3 years, TGTX annual operating profit has risen by +$386.70 million (+112.16%).
  • TGTX annual operating profit is now at all-time high.

Performance

TGTX Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

quarterly operating profit:

$8.62M-$21.33M(-71.21%)
March 1, 2025

Summary

  • As of today (June 22, 2025), TGTX quarterly operating income is $8.62 million, with the most recent change of -$21.33 million (-71.21%) on March 1, 2025.
  • Over the past year, TGTX quarterly operating profit has increased by +$17.89 million (+193.01%).
  • TGTX quarterly operating profit is now -92.49% below its all-time high of $114.78 million, reached on September 30, 2023.

Performance

TGTX quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

TTM operating profit:

$59.82M+$17.89M(+42.67%)
March 1, 2025

Summary

  • As of today (June 22, 2025), TGTX TTM operating income is $59.82 million, with the most recent change of +$17.89 million (+42.67%) on March 1, 2025.
  • Over the past year, TGTX TTM operating profit has increased by +$11.47 million (+23.71%).
  • TGTX TTM operating profit is now -41.26% below its all-time high of $101.84 million, reached on June 30, 2024.

Performance

TGTX TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTGTXincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

TGTX Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+103.2%+193.0%+23.7%
3 y3 years+112.2%+112.9%+118.5%
5 y5 years+124.8%+117.2%+132.4%

TGTX Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+112.2%-92.5%+111.1%-41.3%+118.5%
5 y5-yearat high+112.2%-92.5%+109.3%-41.3%+117.3%
alltimeall timeat high+112.2%-92.5%+109.3%-41.3%+117.3%

TGTX Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$8.62M(-71.2%)
$59.82M(+42.7%)
Dec 2024
$41.93M(+103.2%)
$29.95M(+140.9%)
$41.93M(-8402.8%)
Sep 2024
-
$12.43M(+41.0%)
-$505.00K(-100.5%)
Jun 2024
-
$8.82M(-195.1%)
$101.84M(+110.6%)
Mar 2024
-
-$9.27M(-25.8%)
$48.35M(+134.4%)
Dec 2023
$20.63M(-109.5%)
-$12.48M(-110.9%)
$20.63M(-146.4%)
Sep 2023
-
$114.78M(-356.9%)
-$44.42M(-77.1%)
Jun 2023
-
-$44.67M(+20.8%)
-$194.17M(+3.0%)
Mar 2023
-
-$36.99M(-52.3%)
-$188.44M(-13.7%)
Dec 2022
-$218.32M(-36.7%)
-$77.54M(+121.8%)
-$218.31M(-6.6%)
Sep 2022
-
-$34.96M(-10.2%)
-$233.72M(-17.7%)
Jun 2022
-
-$38.94M(-41.8%)
-$283.89M(-12.0%)
Mar 2022
-
-$66.87M(-28.1%)
-$322.44M(-6.5%)
Dec 2021
-$344.77M(+26.0%)
-$92.95M(+9.2%)
-$344.77M(+1.8%)
Sep 2021
-
-$85.13M(+9.9%)
-$338.60M(-0.2%)
Jun 2021
-
-$77.49M(-13.1%)
-$339.20M(+8.5%)
Mar 2021
-
-$89.20M(+2.8%)
-$312.55M(+14.2%)
Dec 2020
-$273.59M(+61.8%)
-$86.78M(+1.2%)
-$273.59M(+21.7%)
Sep 2020
-
-$85.72M(+68.6%)
-$224.77M(+12.4%)
Jun 2020
-
-$50.84M(+1.2%)
-$199.91M(+8.3%)
Mar 2020
-
-$50.24M(+32.4%)
-$184.61M(+9.2%)
Dec 2019
-$169.06M(-3.1%)
-$37.96M(-37.6%)
-$169.06M(-8.7%)
Sep 2019
-
-$60.86M(+71.2%)
-$185.24M(+16.7%)
Jun 2019
-
-$35.54M(+2.5%)
-$158.71M(-5.3%)
Mar 2019
-
-$34.69M(-35.9%)
-$167.51M(-3.9%)
Dec 2018
-$174.40M(+46.9%)
-$54.15M(+57.7%)
-$174.40M(+15.3%)
Sep 2018
-
-$34.33M(-22.6%)
-$151.28M(+1.8%)
Jun 2018
-
-$44.34M(+6.7%)
-$148.54M(+12.0%)
Mar 2018
-
-$41.58M(+34.0%)
-$132.62M(+11.7%)
Dec 2017
-$118.71M(+50.3%)
-$31.04M(-1.7%)
-$118.71M(+6.3%)
Sep 2017
-
-$31.59M(+11.1%)
-$111.70M(+6.3%)
Jun 2017
-
-$28.43M(+2.7%)
-$105.04M(+13.4%)
Mar 2017
-
-$27.67M(+15.1%)
-$92.64M(+17.3%)
Dec 2016
-$78.97M(+25.0%)
-$24.03M(-3.6%)
-$78.97M(+8.8%)
Sep 2016
-
-$24.93M(+55.6%)
-$72.58M(+18.1%)
Jun 2016
-
-$16.02M(+14.5%)
-$61.48M(-1.7%)
Mar 2016
-
-$13.99M(-20.7%)
-$62.57M(-1.0%)
Dec 2015
-$63.18M(+13.4%)
-$17.64M(+27.6%)
-$63.18M(-1.7%)
Sep 2015
-
-$13.83M(-19.2%)
-$64.26M(-5.3%)
Jun 2015
-
-$17.11M(+17.2%)
-$67.87M(+8.2%)
Mar 2015
-
-$14.60M(-22.0%)
-$62.72M(+12.6%)
Dec 2014
-$55.72M(+176.3%)
-$18.72M(+7.4%)
-$55.72M(+32.1%)
Sep 2014
-
-$17.44M(+45.9%)
-$42.18M(+43.5%)
Jun 2014
-
-$11.96M(+57.2%)
-$29.39M(+22.1%)
Mar 2014
-
-$7.61M(+46.9%)
-$24.06M(+19.3%)
Dec 2013
-$20.17M(-21.8%)
-$5.18M(+11.4%)
-$20.17M(+14.7%)
Sep 2013
-
-$4.65M(-29.9%)
-$17.58M(+12.4%)
Jun 2013
-
-$6.63M(+78.5%)
-$15.64M(+29.1%)
Mar 2013
-
-$3.71M(+43.6%)
-$12.12M(-53.0%)
Dec 2012
-$25.79M(+2824.1%)
-$2.59M(-4.7%)
-$25.79M(+8.5%)
Sep 2012
-
-$2.71M(-12.6%)
-$23.76M(+12.7%)
Jun 2012
-
-$3.10M(-82.1%)
-$21.08M(+15.4%)
Mar 2012
-
-$17.39M(+3033.1%)
-$18.27M(-4.6%)
Dec 2011
-$882.00K(-56.3%)
-$554.90K(+1743.5%)
-$19.15M(+0.6%)
Sep 2011
-
-$30.10K(-89.9%)
-$19.04M(-2.5%)
Jun 2011
-
-$297.00K(-98.4%)
-$19.53M(-1.2%)
Mar 2011
-
-$18.27M(+3990.3%)
-$19.75M(+879.6%)
Dec 2010
-$2.02M
-$446.60K(-13.4%)
-$2.02M(+5.5%)
DateAnnualQuarterlyTTM
Sep 2010
-
-$515.60K(-1.8%)
-$1.91M(+6.7%)
Jun 2010
-
-$525.10K(-0.8%)
-$1.79M(+2.7%)
Mar 2010
-
-$529.40K(+55.1%)
-$1.74M(-1.6%)
Dec 2009
-$1.77M(-59.9%)
-$341.30K(-13.7%)
-$1.77M(+28.6%)
Sep 2009
-
-$395.60K(-17.1%)
-$1.38M(-41.8%)
Jun 2009
-
-$477.30K(-14.4%)
-$2.37M(-29.5%)
Mar 2009
-
-$557.30K(-1165.6%)
-$3.36M(-23.9%)
Dec 2008
-$4.41M(-63.7%)
$52.30K(-103.8%)
-$4.41M(-30.9%)
Sep 2008
-
-$1.38M(-5.7%)
-$6.38M(-17.2%)
Jun 2008
-
-$1.47M(-9.1%)
-$7.71M(-31.0%)
Mar 2008
-
-$1.61M(-15.9%)
-$11.16M(-8.1%)
Dec 2007
-$12.14M(+21.4%)
-$1.92M(-29.1%)
-$12.14M(-9.4%)
Sep 2007
-
-$2.71M(-45.0%)
-$13.41M(+5.9%)
Jun 2007
-
-$4.92M(+89.8%)
-$12.66M(+25.4%)
Mar 2007
-
-$2.59M(-18.4%)
-$10.10M(+1.0%)
Dec 2006
-$10.00M(-48.3%)
-$3.18M(+61.8%)
-$10.00M(-53.2%)
Sep 2006
-
-$1.97M(-16.6%)
-$21.35M(+0.5%)
Jun 2006
-
-$2.36M(-5.6%)
-$21.24M(+4.2%)
Mar 2006
-
-$2.50M(-82.8%)
-$20.40M(+5.4%)
Dec 2005
-$19.36M(+215.1%)
-$14.53M(+680.4%)
-$19.36M(+192.3%)
Sep 2005
-
-$1.86M(+23.3%)
-$6.62M(-5.4%)
Jun 2005
-
-$1.51M(+3.6%)
-$7.00M(+8.1%)
Mar 2005
-
-$1.46M(-18.7%)
-$6.48M(+5.5%)
Dec 2004
-$6.14M(+29.1%)
-$1.79M(-20.1%)
-$6.14M(+4.6%)
Sep 2004
-
-$2.24M(+127.2%)
-$5.87M(+3.6%)
Jun 2004
-
-$986.70K(-12.1%)
-$5.67M(+3.8%)
Mar 2004
-
-$1.12M(-26.2%)
-$5.46M(+14.7%)
Dec 2003
-$4.76M(+367.3%)
-$1.52M(-25.4%)
-$4.76M(+55.0%)
Sep 2003
-
-$2.04M(+162.4%)
-$3.07M(+89.6%)
Jun 2003
-
-$777.00K(+84.0%)
-$1.62M(+48.4%)
Mar 2003
-
-$422.20K(-350.9%)
-$1.09M(-16.0%)
Dec 2002
-$1.02M(-67.2%)
$168.30K(-128.6%)
-$1.30M(-35.9%)
Sep 2002
-
-$588.20K(+136.4%)
-$2.02M(-5.4%)
Jun 2002
-
-$248.80K(-60.5%)
-$2.14M(-36.4%)
Mar 2002
-
-$629.60K(+12.8%)
-$3.37M(+13.7%)
Dec 2001
-$3.11M(-1.7%)
-$558.20K(-20.8%)
-$2.96M(+3382.8%)
Sep 2001
-
-$704.50K(-52.2%)
-$85.00K(-75.3%)
Jun 2001
-
-$1.47M(+556.6%)
-$344.00K(-82.5%)
Mar 2001
-
-$224.40K(-109.7%)
-$1.97M(-37.4%)
Dec 2000
-$3.16M(+17.1%)
$2.32M(-340.5%)
-$3.15M(-48.1%)
Sep 2000
-
-$963.50K(-68.9%)
-$6.06M(+8.3%)
Jun 2000
-
-$3.10M(+120.8%)
-$5.60M(+74.9%)
Mar 2000
-
-$1.40M(+133.8%)
-$3.20M(+14.4%)
Dec 1999
-$2.70M(-15.6%)
-$600.00K(+20.0%)
-$2.80M(-22.2%)
Sep 1999
-
-$500.00K(-28.6%)
-$3.60M(-16.3%)
Jun 1999
-
-$700.00K(-30.0%)
-$4.30M(+53.6%)
Mar 1999
-
-$1.00M(-28.6%)
-$2.80M(-9.7%)
Dec 1998
-$3.20M(-39.6%)
-$1.40M(+16.7%)
-$3.10M(-6.1%)
Sep 1998
-
-$1.20M(-250.0%)
-$3.30M(+6.5%)
Jun 1998
-
$800.00K(-161.5%)
-$3.10M(-44.6%)
Mar 1998
-
-$1.30M(-18.8%)
-$5.60M(+9.8%)
Dec 1997
-$5.30M(+43.2%)
-$1.60M(+60.0%)
-$5.10M(+10.9%)
Sep 1997
-
-$1.00M(-41.2%)
-$4.60M(-2.1%)
Jun 1997
-
-$1.70M(+112.5%)
-$4.70M(+30.6%)
Mar 1997
-
-$800.00K(-27.3%)
-$3.60M(+33.3%)
Dec 1996
-$3.70M
-$1.10M(0.0%)
-$2.70M(+68.8%)
Sep 1996
-
-$1.10M(+83.3%)
-$1.60M(+220.0%)
Jun 1996
-
-$600.00K(-700.0%)
-$500.00K(-600.0%)
Mar 1996
-
$100.00K
$100.00K

FAQ

  • What is TG Therapeutics annual operating income?
  • What is the all time high annual operating profit for TG Therapeutics?
  • What is TG Therapeutics annual operating profit year-on-year change?
  • What is TG Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for TG Therapeutics?
  • What is TG Therapeutics quarterly operating profit year-on-year change?
  • What is TG Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for TG Therapeutics?
  • What is TG Therapeutics TTM operating profit year-on-year change?

What is TG Therapeutics annual operating income?

The current annual operating profit of TGTX is $41.93M

What is the all time high annual operating profit for TG Therapeutics?

TG Therapeutics all-time high annual operating income is $41.93M

What is TG Therapeutics annual operating profit year-on-year change?

Over the past year, TGTX annual operating income has changed by +$21.30M (+103.21%)

What is TG Therapeutics quarterly operating income?

The current quarterly operating profit of TGTX is $8.62M

What is the all time high quarterly operating profit for TG Therapeutics?

TG Therapeutics all-time high quarterly operating income is $114.78M

What is TG Therapeutics quarterly operating profit year-on-year change?

Over the past year, TGTX quarterly operating income has changed by +$17.89M (+193.01%)

What is TG Therapeutics TTM operating income?

The current TTM operating profit of TGTX is $59.82M

What is the all time high TTM operating profit for TG Therapeutics?

TG Therapeutics all-time high TTM operating income is $101.84M

What is TG Therapeutics TTM operating profit year-on-year change?

Over the past year, TGTX TTM operating income has changed by +$11.47M (+23.71%)
On this page